MURALI CHINTAGUMPALA to Retinoblastoma
This is a "connection" page, showing publications MURALI CHINTAGUMPALA has written about Retinoblastoma.
Connection Strength
5.366
-
A multi-institutional feasibility study of intra-arterial chemotherapy in children with retinoblastoma. A Children's Oncology Group study (COG ARET12P1). Pediatr Blood Cancer. 2024 Jan; 71(1):e30718.
Score: 0.814
-
Intensive Multimodality Therapy for Extraocular Retinoblastoma: A Children's Oncology Group Trial (ARET0321). J Clin Oncol. 2022 11 20; 40(33):3839-3847.
Score: 0.747
-
Neonatal Retinoblastoma. Clin Perinatol. 2021 03; 48(1):53-70.
Score: 0.679
-
A single-arm study of systemic and sub-Tenon chemotherapy for Groups C and D intraocular retinoblastoma: A Children's Oncology Group study (ARET 0231). Pediatr Blood Cancer. 2020 09; 67(9):e28502.
Score: 0.648
-
Retinoblastoma in Low- and Middle-Income Countries. Pediatr Hematol Oncol. 2019 03; 36(2):53-54.
Score: 0.591
-
Retinoblastoma: review of current management. Oncologist. 2007 Oct; 12(10):1237-46.
Score: 0.268
-
Response of retinoblastoma with vitreous tumor seeding to adenovirus-mediated delivery of thymidine kinase followed by ganciclovir. J Clin Oncol. 2005 Nov 01; 23(31):7927-35.
Score: 0.235
-
Response criteria for intraocular retinoblastoma: RB-RECIST. Pediatr Blood Cancer. 2021 05; 68(5):e28964.
Score: 0.170
-
Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children's Oncology Group Study. J Clin Oncol. 2019 11 01; 37(31):2883-2891.
Score: 0.154
-
Technical and anatomical factors affecting intra-arterial chemotherapy fluoroscopy time and radiation dose for intraocular retinoblastoma. J Neurointerv Surg. 2019 Dec; 11(12):1273-1276.
Score: 0.151
-
Vitreous Seeds in Retinoblastoma: Clinicopathologic Classification and Correlation. Ophthalmology. 2017 10; 124(10):1540-1547.
Score: 0.131
-
Systemic neoadjuvant chemotherapy for Group B intraocular retinoblastoma (ARET0331): A report from the Children's Oncology Group. Pediatr Blood Cancer. 2017 Jul; 64(7).
Score: 0.127
-
Correlation of Insurance, Race, and Ethnicity with Pathologic Risk in a Controlled Retinoblastoma Cohort: A Children's Oncology Group Study. Ophthalmology. 2016 08; 123(8):1817-1823.
Score: 0.122
-
Residual intraretinal retinoblastoma after chemoreduction failure. Arch Ophthalmol. 2012 Feb; 130(2):246-8.
Score: 0.091
-
Outcomes of integrating genetics in management of patients with retinoblastoma. Arch Ophthalmol. 2011 Nov; 129(11):1428-34.
Score: 0.089
-
High-dose chemotherapy with autologous hematopoietic stem cell rescue for stage 4B retinoblastoma. Pediatr Blood Cancer. 2010 Jul 15; 55(1):149-52.
Score: 0.081
-
Absence of systemic immune response to adenovectors after intraocular administration to children with retinoblastoma. Mol Ther. 2010 Oct; 18(10):1885-90.
Score: 0.081
-
Proceedings of the consensus meetings from the International Retinoblastoma Staging Working Group on the pathology guidelines for the examination of enucleated eyes and evaluation of prognostic risk factors in retinoblastoma. Arch Pathol Lab Med. 2009 Aug; 133(8):1199-202.
Score: 0.076
-
Extensively necrotic retinoblastoma is associated with high-risk prognostic factors. Arch Pathol Lab Med. 2006 Nov; 130(11):1669-72.
Score: 0.063
-
Retinoblastoma: from bench to bedside. Expert Rev Mol Med. 2003 Jan 07; 5(1):1-14.
Score: 0.048